118 related articles for article (PubMed ID: 17990250)
1. Fragmental modeling of human glutamate transporter EAAT1 and analysis of its binding modes by docking and pharmacophore mapping.
Pedretti A; De Luca L; Sciarrillo C; Vistoli G
ChemMedChem; 2008 Jan; 3(1):79-90. PubMed ID: 17990250
[TBL] [Abstract][Full Text] [Related]
2. Modelling of full-length human alpha4beta2 nicotinic receptor by fragmental approach and analysis of its binding modes.
Pedretti A; Marconi C; Bolchi C; Fumagalli L; Ferrara R; Pallavicini M; Valoti E; Vistoli G
Biochem Biophys Res Commun; 2008 May; 369(2):648-53. PubMed ID: 18302933
[TBL] [Abstract][Full Text] [Related]
3. Modeling of the intestinal peptide transporter hPepT1 and analysis of its transport capacities by docking and pharmacophore mapping.
Pedretti A; De Luca L; Marconi C; Negrisoli G; Aldini G; Vistoli G
ChemMedChem; 2008 Dec; 3(12):1913-21. PubMed ID: 18979492
[TBL] [Abstract][Full Text] [Related]
4. Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Pedretti A; De Luca L; Marconi C; Regazzoni L; Aldini G; Vistoli G
Bioorg Med Chem; 2011 Aug; 19(15):4544-51. PubMed ID: 21741846
[TBL] [Abstract][Full Text] [Related]
5. Structure of a glutamate transporter homologue from Pyrococcus horikoshii.
Yernool D; Boudker O; Jin Y; Gouaux E
Nature; 2004 Oct; 431(7010):811-8. PubMed ID: 15483603
[TBL] [Abstract][Full Text] [Related]
6. Accessing a transporter structure.
Kavanaugh MP
Nature; 2004 Oct; 431(7010):752-3. PubMed ID: 15483590
[No Abstract] [Full Text] [Related]
7. Construction of human ghrelin receptor (hGHS-R1a) model using a fragmental prediction approach and validation through docking analysis.
Pedretti A; Villa M; Pallavicini M; Valoti E; Vistoli G
J Med Chem; 2006 Jun; 49(11):3077-85. PubMed ID: 16722627
[TBL] [Abstract][Full Text] [Related]
8. Na(+):aspartate coupling stoichiometry in the glutamate transporter homologue Glt(Ph).
Groeneveld M; Slotboom DJ
Biochemistry; 2010 May; 49(17):3511-3. PubMed ID: 20349989
[TBL] [Abstract][Full Text] [Related]
9. Modeling of human ghrelin receptor (hGHS-R1a) in its close state and validation by molecular docking.
Pedretti A; Vistoli G
Bioorg Med Chem; 2007 Apr; 15(8):3054-64. PubMed ID: 17329109
[TBL] [Abstract][Full Text] [Related]
10. Structure and molecular dynamics simulation of archaeal prefoldin: the molecular mechanism for binding and recognition of nonnative substrate proteins.
Ohtaki A; Kida H; Miyata Y; Ide N; Yonezawa A; Arakawa T; Iizuka R; Noguchi K; Kita A; Odaka M; Miki K; Yohda M
J Mol Biol; 2008 Feb; 376(4):1130-41. PubMed ID: 18201719
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into human 5-lipoxygenase inhibition: combined ligand-based and target-based approach.
Charlier C; Hénichart JP; Durant F; Wouters J
J Med Chem; 2006 Jan; 49(1):186-95. PubMed ID: 16392803
[TBL] [Abstract][Full Text] [Related]
12. Binding of serotonin to the human serotonin transporter. Molecular modeling and experimental validation.
Celik L; Sinning S; Severinsen K; Hansen CG; Møller MS; Bols M; Wiborg O; Schiøtt B
J Am Chem Soc; 2008 Mar; 130(12):3853-65. PubMed ID: 18314975
[TBL] [Abstract][Full Text] [Related]
13. Characterization of binding site of closed-state KCNQ1 potassium channel by homology modeling, molecular docking, and pharmacophore identification.
Du LP; Li MY; Tsai KC; You QD; Xia L
Biochem Biophys Res Commun; 2005 Jul; 332(3):677-87. PubMed ID: 15904893
[TBL] [Abstract][Full Text] [Related]
14. Molecular docking for substrate identification: the short-chain dehydrogenases/reductases.
Favia AD; Nobeli I; Glaser F; Thornton JM
J Mol Biol; 2008 Jan; 375(3):855-74. PubMed ID: 18036612
[TBL] [Abstract][Full Text] [Related]
15. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
Wei HY; Lu CS; Lin TH
J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
[TBL] [Abstract][Full Text] [Related]
16. Structures of dimeric nonstandard nucleotide triphosphate pyrophosphatase from Pyrococcus horikoshii OT3: functional significance of interprotomer conformational changes.
Lokanath NK; Pampa KJ; Takio K; Kunishima N
J Mol Biol; 2008 Jan; 375(4):1013-25. PubMed ID: 18062990
[TBL] [Abstract][Full Text] [Related]
17. Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6.
de Groot MJ; Ackland MJ; Horne VA; Alex AA; Jones BC
J Med Chem; 1999 May; 42(9):1515-24. PubMed ID: 10229622
[TBL] [Abstract][Full Text] [Related]
18. Predicting multiple ligand binding modes using self-consistent pharmacophore hypotheses.
Wallach I; Lilien R
J Chem Inf Model; 2009 Sep; 49(9):2116-28. PubMed ID: 19711952
[TBL] [Abstract][Full Text] [Related]
19. Interactions of alkali cations with glutamate transporters.
Holley DC; Kavanaugh MP
Philos Trans R Soc Lond B Biol Sci; 2009 Jan; 364(1514):155-61. PubMed ID: 18977733
[TBL] [Abstract][Full Text] [Related]
20. Repositioning of transmembrane alpha-helices during membrane protein folding.
Kauko A; Hedin LE; Thebaud E; Cristobal S; Elofsson A; von Heijne G
J Mol Biol; 2010 Mar; 397(1):190-201. PubMed ID: 20109468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
